4//SEC Filing
SELBY NORMAN C 4
Accession 0001140361-21-017889
CIK 0001113148other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:32 PM ET
Size
6.9 KB
Accession
0001140361-21-017889
Insider Transaction Report
Form 4
SELBY NORMAN C
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-05-14−5,000→ 35,000 totalExercise: $0.92Exp: 2030-06-17→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-05-14$0.92/sh+5,000$4,600→ 15,000 total
Footnotes (1)
- [F1]On June 17, 2020, the Reporting Person was granted 40,000 stock options, 30,000 of which were eligible to vest as long as the holder continued to serve as a director of the issuer and 10,000 of which were eligible to vest as long as the holder continued to serve as Lead Independent Director of the issuer's Board of Directors. The stock options vested over a period of one year in equal quarterly installments beginning at the end of the first calendar quarter after the date of grant. All 40,000 stock options are currently exercisable.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001192613
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:32 PM ET
- Size
- 6.9 KB